Acquisition Completed

Fulgent Genetics acquisition of Bako Diagnostics selected assets

US$56.9m consideration

Announced 22 Dec 2025

Advisers

Bako Diagnostics selected assets

Target

Financial adviser
EV Health Partners
Legal adviser

Fulgent Genetics

Acquirer

Financial adviser
Legal adviser
Target
Bako Diagnostics selected assets
Acquirer
Fulgent Genetics
Target based in
United States (unverified)
Buyer based in
United States
Completed
17 Mar 2026
Sector
Diagnostics
Tags
Diagnostics, Healthcare Services

In the league tables

Similar deals

All diagnostics deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.